Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats

Neurobiology of Disease

Volumn 39, Issue 3, 2010, Pages 252-264

  Lepore, Angelo C ^a   Tolmie, Christopher ^a   O'Donnell, John ^a   Wright, Megan C ^a   Dejea, Christine ^a   Rauck, Britta ^a   Hoke, Ahmet ^a   Ignagni, Anthony R ^b   Onders, Raymond P ^c   Maragakis, Nicholas J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Synapse Biomedical Inc   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALS; Amyotrophic lateral sclerosis; Diaphragm; Diaphragm pacing; Diaphragm stimulation; Disease onset; Environment; Motor neuron; Neurodegeneration; Phrenic nerve; Respiratory; SOD1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; DISEASE EXACERBATION; FEMALE; FORELIMB; GLIOSIS; GRIP STRENGTH; LIFESPAN; MALE; MOTOR PERFORMANCE; MUSCLE ACTION POTENTIAL; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; SPINAL CORD MOTONEURON; WEIGHT REDUCTION;

EID: 77954953414     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.03.021     Document Type: Article

References (45)

1. Andersen P.M., et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997, 120(Pt 10):1723-1737.
2. Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J. Neurol. Sci. 2007, 262:45-53.
3. Boillee S., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
4. Boulenguez P., et al. Specific and artifactual labeling in the rat spinal cord and medulla after injection of monosynaptic retrograde tracers into the diaphragm. Neurosci. Lett. 2007, 417:206-211.
5. Bruijn L.I., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338.
6. Chen A., et al. The role of exercise in amyotrophic lateral sclerosis. Phys. Med. Rehabil. Clin. N. Am. 2008, 19:545-557.
7. Cudkowicz M.E., et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 1997, 41:210-221.
8. Fischer L.R., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185:232-240.
9. Franz C.K., et al. A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis. PLoS ONE 2009, 4:e7357.
10. Gurney M.E., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
11. Haley R.W. Excess incidence of ALS in young Gulf War veterans. Neurology 2003, 61:750-756.
12. Haverkamp L.J., et al. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995, 118(Pt 3):707-719.
13. Horner R.D., et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003, 61:742-749.
14. Howland D.S., et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1604-1609.
15. Ikeda K., et al. Motoneuron degeneration after facial nerve avulsion is exacerbated in presymptomatic transgenic rats expressing human mutant Cu/Zn superoxide dismutase. J. Neurosci. Res. 2005, 82:63-70.
16. Jafari H., et al. Motor neuron disease after electric injury. J. Neurol. Neurosurg. Psychiatry 2001, 71:265-267.
17. Kirkinezos I.G., et al. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 2003, 53:804-807.
18. Kong J., Xu Z. Peripheral axotomy slows motoneuron degeneration in a transgenic mouse line expressing mutant SOD1 G93A. J. Comp. Neurol. 1999, 412:373-380.
19. Kriz J., et al. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2002, 10:268-278.
20. Kurtzke J.F. Risk factors in amyotrophic lateral sclerosis. Adv. Neurol. 1991, 56:245-270.
21. Lepore A.C., et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 2008, 11:1294-1301.
22. Liebetanz D., et al. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur. J. NeuroSci. 2004, 20:3115-3120.
23. Llado J., et al. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol. Dis. 2006, 21:110-118.
24. Lo Coco D., et al. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006, 67:761-765.
25. Love F.M., et al. Activity alters muscle reinnervation and terminal sprouting by reducing the number of Schwann cell pathways that grow to link synaptic sites. J. Neurobiol. 2003, 54:566-576.
26. Mahoney D.J., et al. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2004, 29:656-662.
27. Mariotti R., et al. Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis. Neuroscience 2002, 115:331-335.
28. Matsumoto A., et al. Disease progression of human SOD1 (G93A) transgenic ALS model rats. J. Neurosci. Res. 2006, 83:119-133.
29. Mattson M.P. Infectious agents and age-related neurodegenerative disorders. Ageing Res. Rev. 2004, 3:105-120.
30. McCrate M.E., Kaspar B.K. Physical activity and neuroprotection in amyotrophic lateral sclerosis. Neuromolecular Med. 2008, 10:108-117.
31. Mitsumoto H., et al. Amyotrophic lateral sclerosis 1998, F.A. Davis, Philadelphia.
32. Nagai M., et al. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 2001, 21:9246-9254.
33. Oda T., et al. Evaluation of electrical parameters for diaphragm pacing: an experimental study. J. Surg. Res. 1981, 30:142-153.
34. Ravits J., Traynor B.J. Current and future directions in genomics of amyotrophic lateral sclerosis. Phys. Med. Rehabil. Clin. N. Am. 2008, 19:461-477. viii.
35. Rosen D.R., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
36. Sargsyan S.A., et al. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005, 51:241-253.
37. Sharp P.S., et al. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 2005, 130:897-910.
38. Sutedja N.A., et al. What we truly know about occupation as a risk factor for ALS: a critical and systematic review. Amyotroph Lateral Scler. 2008, 1-19.
39. Sutedja N.A., et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler. 2008, 1-20.
40. Van Den Bosch L., et al. Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport 2002, 13:1067-1070.
41. Veldink J.H., et al. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 2003, 13:737-743.
42. Wong P.C., et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14:1105-1116.
43. Wright M.C., et al. Distinct patterns of motor nerve terminal sprouting induced by ciliary neurotrophic factor vs. botulinum toxin. J. Comp. Neurol. 2007, 504:1-16.
44. Yamanaka K., et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.
45. Zhu S., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.